BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: von Schönfels W, Buch S, Wölk M, Aselmann H, Egberts JH, Schreiber S, Krawczak M, Becker T, Hampe J, Schafmayer C. Recurrence of gallstones after cholecystectomy is associated with ABCG5/8 genotype. J Gastroenterol 2013;48:391-6. [PMID: 22869156 DOI: 10.1007/s00535-012-0639-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang HH, Li T, Portincasa P, Ford DA, Neuschwander-Tetri BA, Tso P, Wang DQ. New insights into the role of Lith genes in the formation of cholesterol-supersaturated bile. Liver Res 2017;1:42-53. [PMID: 34367715 DOI: 10.1016/j.livres.2017.05.005] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
2 Di Ciaula A, Wang DQ, Portincasa P. Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention. Expert Rev Gastroenterol Hepatol 2019;13:157-71. [PMID: 30791781 DOI: 10.1080/17474124.2019.1549988] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
3 Wang HH, Liu M, Portincasa P, Wang DQ. Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease. Adv Exp Med Biol 2020;1276:105-36. [PMID: 32705597 DOI: 10.1007/978-981-15-6082-8_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Di Ciaula A, Wang DQ, Portincasa P. An update on the pathogenesis of cholesterol gallstone disease. Curr Opin Gastroenterol 2018;34:71-80. [PMID: 29283909 DOI: 10.1097/MOG.0000000000000423] [Cited by in Crossref: 68] [Cited by in F6Publishing: 50] [Article Influence: 22.7] [Reference Citation Analysis]
5 Wang DQ, Neuschwander-tetri BA, Portincasa P. The Biliary System, Second Edition. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2016;8:i-178. [DOI: 10.4199/c00147ed2v01y201611isp071] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Di Ciaula A, Portincasa P. Recent advances in understanding and managing cholesterol gallstones. F1000Res. 2018;7. [PMID: 30345010 DOI: 10.12688/f1000research.15505.1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
7 Wang TY, Portincasa P, Liu M, Tso P, Wang DQ. Mouse models of gallstone disease. Curr Opin Gastroenterol 2018;34:59-70. [PMID: 29266008 DOI: 10.1097/MOG.0000000000000417] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
8 Wang P, Tao H, Liu C, Zhou X, Sun B, Zhu C, Li K, Fang Z. One-step percutaneous transhepatic cholangioscopic lithotripsy in patients with choledocholithiasis. Clin Res Hepatol Gastroenterol 2021;45:101477. [PMID: 33744724 DOI: 10.1016/j.clinre.2020.06.003] [Reference Citation Analysis]
9 Elderman JH, ter Borg PC, Dees J, Dees A. Pregnancy and ABCB4 gene mutation: risk of recurrent cholelithiasis. BMJ Case Rep 2015;2015:bcr2014206919. [PMID: 25612754 DOI: 10.1136/bcr-2014-206919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Wu Y, Xu CJ, Xu SF. Advances in Risk Factors for Recurrence of Common Bile Duct Stones. Int J Med Sci 2021;18:1067-74. [PMID: 33456365 DOI: 10.7150/ijms.52974] [Reference Citation Analysis]